HUP0003118A3 - Use of 2,7-substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives for production of pharmaceutical compositions - Google Patents
Use of 2,7-substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives for production of pharmaceutical compositionsInfo
- Publication number
- HUP0003118A3 HUP0003118A3 HU0003118A HUP0003118A HUP0003118A3 HU P0003118 A3 HUP0003118 A3 HU P0003118A3 HU 0003118 A HU0003118 A HU 0003118A HU P0003118 A HUP0003118 A HU P0003118A HU P0003118 A3 HUP0003118 A3 HU P0003118A3
- Authority
- HU
- Hungary
- Prior art keywords
- pyrido
- production
- pharmaceutical compositions
- pyrazine derivatives
- substituted octahydro
- Prior art date
Links
- ONHPOXROAPYCGT-UHFFFAOYSA-N 2,3,4,6,7,8,9,9a-octahydro-1h-pyrido[1,2-a]pyrazine Chemical class C1CNCC2CCCCN21 ONHPOXROAPYCGT-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/368,984 US6231833B1 (en) | 1999-08-05 | 1999-08-05 | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0003118D0 HU0003118D0 (en) | 2000-10-28 |
HUP0003118A2 HUP0003118A2 (hu) | 2001-04-28 |
HUP0003118A3 true HUP0003118A3 (en) | 2002-11-28 |
Family
ID=23453575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0003118A HUP0003118A3 (en) | 1999-08-05 | 2000-08-04 | Use of 2,7-substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives for production of pharmaceutical compositions |
Country Status (11)
Country | Link |
---|---|
US (4) | US6231833B1 (hu) |
EP (1) | EP1074257A1 (hu) |
JP (2) | JP2001064178A (hu) |
KR (1) | KR20010021215A (hu) |
AU (1) | AU775093B2 (hu) |
CA (1) | CA2314867A1 (hu) |
CO (1) | CO5180647A1 (hu) |
HU (1) | HUP0003118A3 (hu) |
IL (1) | IL137554A0 (hu) |
NZ (2) | NZ515882A (hu) |
PE (1) | PE20010481A1 (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
EP1177792A3 (en) | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
US6670476B2 (en) * | 2000-11-29 | 2003-12-30 | Pfizer Inc. | Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine |
CA2364211A1 (en) * | 2000-12-05 | 2002-06-05 | Phillip Branch Chappell | Combination treatment for depression, anxiety and psychosis |
WO2002060492A1 (en) * | 2001-01-30 | 2002-08-08 | Cytopia Pty Ltd | Methods of inhibiting kinases |
FR2827288B1 (fr) * | 2001-07-12 | 2003-10-31 | Servier Lab | Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU2002950217A0 (en) | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
US6855014B2 (en) * | 2002-07-19 | 2005-02-15 | Yamaha Marine Kabushiki Kaisha | Control for watercraft propulsion system |
US7694151B1 (en) * | 2003-11-20 | 2010-04-06 | Johnson Richard C | Architecture, system, and method for operating on encrypted and/or hidden information |
US20070218002A1 (en) * | 2004-05-07 | 2007-09-20 | Barrio Jorge R | Method for Detecting Alzheimer's Disease and other Forms of Dementia, and Measuring Their Progression |
WO2006000914A1 (en) * | 2004-06-22 | 2006-01-05 | Pfizer Products Inc. | Diazabicyclic histamine-3 receptor antagonists |
TW200801005A (en) * | 2005-08-15 | 2008-01-01 | Astrazeneca Ab | Acetylenic piperazines as metabotropic glutamate receptor antagonists |
US20120040974A1 (en) * | 2008-08-18 | 2012-02-16 | Yale University | Mif modulators |
US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
CN108409728B (zh) * | 2017-02-09 | 2020-11-24 | 广东东阳光药业有限公司 | 苯基八氢-1H-吡啶并[1,2-a]吡嗪衍生物及其用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008148A1 (en) | 1989-01-23 | 1990-07-26 | Pfizer Inc. | Bis-aza-bicyclic anxiolytic agents |
WO1992000075A1 (en) | 1990-06-29 | 1992-01-09 | Pfizer Inc. | Pyridopyrazine derivatives for treating substance abuse and addiction |
US5157034A (en) | 1991-02-27 | 1992-10-20 | Pfizer Inc. | Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines |
AU645681B2 (en) | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
CN1068327C (zh) | 1994-09-30 | 2001-07-11 | 辉瑞大药厂 | 2,7-取代的八氢-1H-吡啶并[1,2-a]吡嗪衍生物 |
US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
US5602128A (en) | 1994-12-02 | 1997-02-11 | American Home Products Corporation | N-heterocycloalkyl carboxamides as serotonergic agents |
US5741789A (en) * | 1995-01-17 | 1998-04-21 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
WO1996023789A1 (fr) | 1995-02-03 | 1996-08-08 | Sankyo Company, Limited | Derives d'hexahydropyrazinoquinoline |
AU6542896A (en) | 1995-07-11 | 1997-02-10 | Merck & Co., Inc. | A triazolylmethyl-indole ethylamine bisulfate salt |
ATE192042T1 (de) | 1995-08-16 | 2000-05-15 | Lilly Co Eli | Potenzierung von serotonin-wirkstoffresponz |
GB9517381D0 (en) | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
AR004229A1 (es) | 1995-11-06 | 1998-11-04 | Wyeth Corp | Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos |
EA200001050A1 (ru) | 1998-04-09 | 2001-04-23 | Смитклайн Бичам Плс | Малеат пароксетина |
PA8469101A1 (es) * | 1998-04-09 | 2000-09-29 | Pfizer Prod Inc | Ligandos azabiciclicos de receptores 5ht1 |
-
1999
- 1999-08-05 US US09/368,984 patent/US6231833B1/en not_active Expired - Fee Related
-
2000
- 2000-07-27 IL IL13755400A patent/IL137554A0/xx unknown
- 2000-08-02 AU AU48976/00A patent/AU775093B2/en not_active Ceased
- 2000-08-03 PE PE2000000776A patent/PE20010481A1/es not_active Application Discontinuation
- 2000-08-03 EP EP00306611A patent/EP1074257A1/en not_active Withdrawn
- 2000-08-03 CA CA002314867A patent/CA2314867A1/en not_active Abandoned
- 2000-08-04 HU HU0003118A patent/HUP0003118A3/hu unknown
- 2000-08-04 NZ NZ51588200A patent/NZ515882A/xx unknown
- 2000-08-04 NZ NZ506154A patent/NZ506154A/en unknown
- 2000-08-04 CO CO00058846A patent/CO5180647A1/es not_active Application Discontinuation
- 2000-08-04 KR KR1020000045207A patent/KR20010021215A/ko not_active Application Discontinuation
- 2000-08-04 JP JP2000236825A patent/JP2001064178A/ja active Pending
-
2001
- 2001-02-15 US US09/784,567 patent/US20020132811A1/en not_active Abandoned
-
2002
- 2002-08-07 US US10/213,604 patent/US20030055061A1/en not_active Abandoned
-
2003
- 2003-10-03 JP JP2003345180A patent/JP2004010619A/ja active Pending
-
2004
- 2004-05-24 US US10/852,611 patent/US7220753B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUP0003118A2 (hu) | 2001-04-28 |
HU0003118D0 (en) | 2000-10-28 |
US6231833B1 (en) | 2001-05-15 |
PE20010481A1 (es) | 2001-04-21 |
CA2314867A1 (en) | 2001-02-05 |
JP2001064178A (ja) | 2001-03-13 |
US20020132811A1 (en) | 2002-09-19 |
US20040214830A1 (en) | 2004-10-28 |
NZ515882A (en) | 2004-12-24 |
AU775093B2 (en) | 2004-07-15 |
AU4897600A (en) | 2001-02-08 |
IL137554A0 (en) | 2001-07-24 |
EP1074257A1 (en) | 2001-02-07 |
NZ506154A (en) | 2002-03-01 |
KR20010021215A (ko) | 2001-03-15 |
JP2004010619A (ja) | 2004-01-15 |
US20030055061A1 (en) | 2003-03-20 |
US7220753B2 (en) | 2007-05-22 |
CO5180647A1 (es) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0303350A3 (en) | Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting pharmaceutical compositions | |
AU2001291893A1 (en) | Use of substituted imidazo(1,2-a)pyridine-, imidazo(1,2-a)pyrimidine and imidazo(1,2-a)pyrazine-3-yl-amine derivatives for producing NOS-inhibiting medicaments | |
HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
HUP0401083A3 (en) | 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds | |
HUP0202103A3 (en) | 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives, their use, pharmaceutical compositions containing them, process for the preparation of the compounds and intermediates | |
HUP0204246A3 (en) | Novel thiazolo[4,5-d]pyrimidine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203450A3 (en) | Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use | |
HUP0105079A3 (en) | Indole derivatives and their use as mcp-1 antagonists, process for preparation of the compounds and medicaments containing them | |
HUP0202100A3 (en) | Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same | |
HUP0105081A3 (en) | Triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
IL191960A (en) | History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them | |
HUP0203052A3 (en) | Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0003118A3 (en) | Use of 2,7-substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives for production of pharmaceutical compositions | |
NZ330988A (en) | 5h-thiazolo[3,2-a]pyrimidine derivatives used as neurological medicaments | |
HUP0203140A3 (en) | Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them | |
AU2177001A (en) | Use of indirubine derivatives for making medicines | |
HUP0102981A3 (en) | Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof | |
HUP0105132A3 (en) | Process for preparing imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones and the use of the same for preparing pharmaceutical compositions | |
IL190120A0 (en) | PREPARATION OF 9-AMINO OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a//1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES | |
HUP0002963A3 (en) | Use of pyrazolo-[4,3-d] pyrimidinon derivatives for the production of pharmaceutical compositions for treating diseases of the eye field | |
HUP0105054A3 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation | |
AU5426500A (en) | Benzazepine derivatives, process for the preparation of the same and uses thereof | |
HUP0004007A3 (en) | New polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0402282A3 (en) | Triazolo[1,5a] quinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP9900611A3 (en) | 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives, pharmaceutical compositions containing them and intermediates for the preparation of the compounds |